4//SEC Filing
Riley Brigit 4
Accession 0001209191-22-050952
CIK 0001501756other
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 7:58 PM ET
Size
5.5 KB
Accession
0001209191-22-050952
Insider Transaction Report
Form 4
Riley Brigit
Chief Scientific Officer
Transactions
- Sale
Common Stock
2022-09-19$1.07/sh−7,266$7,772→ 118,734 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlement of certain performance stock units.
- [F2]Price reported is a weighted-average sale price. The shares were sold at prices ranging from $1.069589 to $1.075. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F3]Includes 6,000 shares purchased on May 20, 2022 pursuant to the Issuer's 2014 Employee Stock Purchase Plan, as amended and restated.
Documents
Issuer
Adverum Biotechnologies, Inc.
CIK 0001501756
Entity typeother
Related Parties
1- filerCIK 0001882857
Filing Metadata
- Form type
- 4
- Filed
- Sep 20, 8:00 PM ET
- Accepted
- Sep 21, 7:58 PM ET
- Size
- 5.5 KB